Patent · US Revoked

Solid forms of Cerdulatinib

US11661414B2 · kind B2 · utility

0Cited by
14References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 16, 2020
Grant dateMay 30, 2023
Priority date
Expiry dateNov 16, 2040

Classification

  • Technology area (CPC —)General

Abstract

Forms of cerdulatinib and salts or co-crystals thereof were prepared and characterized in the solid state. Also provided are processes of manufacture and methods of using the forms cerdulatinib and salts or co-crystals thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.